Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 3, 2021

Primary Completion Date

March 1, 2021

Study Completion Date

September 1, 2021

Conditions
MyalgiaBruxismQuality of Life
Interventions
DRUG

Botulinum toxin

Botulinum toxin, produced by Clostridium botulinum, is a neurotoxin. Presently, there are 7 serotypes (A, B, C1, D, E, F, G). Botulinum neurotoxin A (BoNT-A) is the most frequently used variant in clinical applications.

PROCEDURE

Dry needling

Dry needling (DN) is a type of acupuncture therapy, that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points (MTrPs) and muscular, and connective tissues.

DRUG

Myorel

Metacarbamol (380mg), paracetamol (300mg)

PROCEDURE

Manual therapy

Manual therapy (MT) entails the use of the hands to apply a force with a therapeutic intent, including techniques such as massage, joint mobilization/manipulation, myofascial release, nerve manipulation, strain/counterstrain, and acupressure.

Trial Locations (1)

Unknown

University of Health Sciences, Istanbul

All Listed Sponsors
lead

Saglik Bilimleri Universitesi

OTHER

NCT06583551 - Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia | Biotech Hunter | Biotech Hunter